BackPalvella Therapeutics Overview
Palvella Therapeutics, Inc.

Palvella Therapeutics Target Price

Analysts' 12-month price predictions for PVLA.

Get informed when a big investor buys or sells

+ Follow

Share Price

$146.76

Average Target Price

$220.0049.9% upside

1 analysts in the last 4 months

High: $220 | Low: $220

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-12Stephens$22049.9% upsideOpen
2026-02-24Truist Financial$21043.1% upsideOpen
2026-02-24Chardan Capital$21043.1% upsideOpen
2026-02-24Stifel Nicolaus$25070.3% upsideOpen
2026-02-24H.C. Wainwright$25573.8% upsideOpen
2026-01-07Mizuho Securities$20539.7% upsideOpen
2025-12-16Canaccord GenuityWhitney Ijem$20439% upsideOpen
2025-12-16Raymond JamesRyan Deschner$19331.5% upsideOpen
2025-12-15Chardan Capital$17418.6% upsideOpen
2025-12-15BTIGJeff Mukherjee$19230.8% upsideOpen
2025-12-15Truist Financial$19029.5% upsideOpen
2025-12-15UBSCatherine Novack$1432.6% downsideOpen
2025-12-15H.C. Wainwright$20036.3% upsideOpen
2025-12-15Cantor Fitzgerald$21043.1% upsideOpen
2025-12-15Oppenheimer$20036.3% upsideOpen
2025-12-11H.C. WainwrightAndrew Fein$19029.5% upsideOpen
2025-12-05BTIG$16713.8% upsideOpen
2025-12-04Craig-HallumAlbert Lowe$17519.2% upsideOpen
2025-11-24Stifel NicolausSamimy Annabel$1451.2% downsideOpen
2025-11-19Raymond James$1432.6% downsideOpen
2025-11-06Cantor Fitzgerald$20036.3% upsideOpen
2025-10-09Canaccord Genuity$9038.7% downsideOpen
2025-10-07Cantor Fitzgerald$12018.2% downsideOpen
2025-10-02Truist FinancialDanielle Brill$8045.5% downsideOpen
2025-09-25H.C. Wainwright$9535.3% downsideOpen
2025-09-24Stifel NicolausAnnabel Samimy$8045.5% downsideOpen
2025-09-09Oppenheimer$8542.1% downsideOpen
2025-08-15H.C. WainwrightAndres Maldonado$7548.9% downsideOpen
2025-08-05Raymond James$5463.2% downsideOpen
2025-05-16Canaccord GenuityWhitney Ijem$5264.6% downsideOpen
2025-03-25Stifel NicolausAnnabel Samimy$4569.3% downsideOpen
2024-12-18Cantor FitzgeraldJosh Schimmer$3079.6% downsideOpen